• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病中体内tau蛋白和β淀粉样蛋白积累的时间轨迹。

Temporal trajectories of in vivo tau and amyloid-β accumulation in Alzheimer's disease.

作者信息

Baek Min Seok, Cho Hanna, Lee Hye Sun, Choi Jae Yong, Lee Jae Hoon, Ryu Young Hoon, Lee Myung Sik, Lyoo Chul Hyoung

机构信息

Department of Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.

Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, South Korea.

出版信息

Eur J Nucl Med Mol Imaging. 2020 Nov;47(12):2879-2886. doi: 10.1007/s00259-020-04773-3. Epub 2020 Apr 29.

DOI:10.1007/s00259-020-04773-3
PMID:32350558
Abstract

PURPOSE

To investigate the temporal trajectories of tau and amyloid-β (Aβ) accumulation in Alzheimer's disease (AD) by using the longitudinal positron emission tomography (PET) study.

METHODS

A total of 132 participants, who were healthy volunteers or recruited in our memory disorder clinic, completed longitudinal F-flortaucipir and F-florbetaben PET studies with a mean follow-up time of 2 years. Referencing baseline data from 57 Aβ-negative cognitively unimpaired individuals, Z-scores and their annual changes were calculated with the global cortical or regional standardized uptake value ratios measured at baseline and follow-up after correcting for partial volume effect. The temporal trajectories of tau and Aβ burden as a function of time were obtained based on the spline models from the annual changes and baseline Z-score data.

RESULTS

Tau burden first emerged in the Braak's stage I-II regions, followed by stage III-IV regions, and finally in the stage V-VI regions. Time intervals between two time points at which Z-score curves rose above 2 were 17.3 years for the stages I-II and III-IV and 15.2 years for the stages III-IV and V-VI. Rise in the tau curve for stages I-II preceded that for global cortical Aβ, while the rise in global cortical Aβ curve preceded that for global cortical tau. Aβ accumulation rate was attenuated during the surge in tau burden in the global cortex and reached a plateau.

CONCLUSION

Sequential appearance of Aβ and tau accumulation supports a hypothetical dynamic biomarker model and Braak's hierarchical tau spreading model in AD.

摘要

目的

通过纵向正电子发射断层扫描(PET)研究,调查阿尔茨海默病(AD)中tau蛋白和淀粉样β蛋白(Aβ)积累的时间轨迹。

方法

共有132名参与者,包括健康志愿者或在我们记忆障碍诊所招募的人员,完成了纵向F-氟代tau蛋白配体和F-氟代贝他班PET研究,平均随访时间为2年。以57名Aβ阴性认知未受损个体的基线数据为参照,在校正部分容积效应后,根据基线和随访时测量的全脑皮质或区域标准化摄取值比率计算Z分数及其年度变化。基于年度变化和基线Z分数数据的样条模型,得出tau蛋白和Aβ负担随时间变化的时间轨迹。

结果

tau蛋白负担首先出现在Braak分期的I-II期区域,随后是III-IV期区域,最后是V-VI期区域。Z分数曲线上升超过2的两个时间点之间的时间间隔,I-II期和III-IV期为17.3年,III-IV期和V-VI期为15.2年。I-II期tau蛋白曲线的上升先于全脑皮质Aβ曲线,而全脑皮质Aβ曲线的上升先于全脑皮质tau蛋白曲线。在全脑皮质tau蛋白负担激增期间,Aβ积累速率减弱并达到平台期。

结论

Aβ和tau蛋白积累的顺序出现支持了AD中假设的动态生物标志物模型和Braak的tau蛋白分层扩散模型。

相似文献

1
Temporal trajectories of in vivo tau and amyloid-β accumulation in Alzheimer's disease.阿尔茨海默病中体内tau蛋白和β淀粉样蛋白积累的时间轨迹。
Eur J Nucl Med Mol Imaging. 2020 Nov;47(12):2879-2886. doi: 10.1007/s00259-020-04773-3. Epub 2020 Apr 29.
2
Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages.18F-MK-6240 tau 缠结的纵向积累遵循 Braak 分期。
Brain. 2021 Dec 16;144(11):3517-3528. doi: 10.1093/brain/awab248.
3
Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.氟替卡匹尔PET tau蛋白结合与淀粉样蛋白负荷、临床诊断、年龄和认知之间的关系。
Brain. 2017 Mar 1;140(3):748-763. doi: 10.1093/brain/aww334.
4
Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer's disease.载脂蛋白 E ε4 基因型对阿尔茨海默病中淀粉样蛋白-β 和 tau 积累的影响。
Alzheimers Res Ther. 2020 Oct 31;12(1):140. doi: 10.1186/s13195-020-00710-6.
5
Tau pathology as determinant of changes in atrophy and cerebral blood flow: a multi-modal longitudinal imaging study.tau 病理学作为萎缩和脑血流变化的决定因素:一项多模态纵向影像学研究。
Eur J Nucl Med Mol Imaging. 2023 Jul;50(8):2409-2419. doi: 10.1007/s00259-023-06196-2. Epub 2023 Mar 28.
6
Rates of regional tau accumulation in ageing and across the Alzheimer's disease continuum: an AIBL F-MK6240 PET study.衰老过程中和阿尔茨海默病连续体中区域 tau 积累的速率:AIBL F-MK6240 PET 研究。
EBioMedicine. 2023 Feb;88:104450. doi: 10.1016/j.ebiom.2023.104450. Epub 2023 Jan 27.
7
Progressive Tau Accumulation in Alzheimer Disease: 2-Year Follow-up Study.阿尔茨海默病中 Tau 蛋白的进行性积累:2 年随访研究。
J Nucl Med. 2019 Nov;60(11):1611-1621. doi: 10.2967/jnumed.118.221697. Epub 2019 Mar 29.
8
Association of Basal Forebrain Volume with Amyloid, Tau, and Cognition in Alzheimer's Disease.基底前脑体积与阿尔茨海默病中淀粉样蛋白、tau 蛋白和认知的关联。
J Alzheimers Dis. 2024;99(1):145-159. doi: 10.3233/JAD-230975.
9
One-Year Longitudinal Changes in Tau Accumulation on [F]PI-2620 PET in the Alzheimer Spectrum.阿尔茨海默病谱中 [F]PI-2620 PET 上 tau 积聚的一年纵向变化。
J Nucl Med. 2024 Mar 1;65(3):453-461. doi: 10.2967/jnumed.123.265893.
10
Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders.RO948 F 18 tau 正电子发射断层扫描在阿尔茨海默病与其他神经退行性疾病鉴别诊断中的性能。
JAMA Neurol. 2020 Aug 1;77(8):955-965. doi: 10.1001/jamaneurol.2020.0989.

引用本文的文献

1
Quantification of baseline amyloid PET in individuals with subjective cognitive decline can identify risk of amyloid accumulation and cognitive worsening: the FACEHBI study.主观认知下降个体的基线淀粉样蛋白PET定量可识别淀粉样蛋白积累和认知恶化风险:FACEHBI研究
Eur J Nucl Med Mol Imaging. 2025 Apr 23. doi: 10.1007/s00259-025-07270-7.
2
Amyloid-β but not tau accumulation is strongly associated with longitudinal cognitive decline.淀粉样蛋白-β而非 tau 积聚与纵向认知能力下降密切相关。
CNS Neurosci Ther. 2024 Jul;30(7):e14860. doi: 10.1111/cns.14860.
3
A review of the flortaucipir literature for positron emission tomography imaging of tau neurofibrillary tangles.

本文引用的文献

1
Estimating long-term multivariate progression from short-term data.从短期数据估计长期多变量进展。
Alzheimers Dement. 2014 Oct;10(5 Suppl):S400-10. doi: 10.1016/j.jalz.2013.10.003. Epub 2014 Mar 20.
一篇关于用于tau神经原纤维缠结正电子发射断层扫描成像的氟替卡匹文献综述。
Brain Commun. 2023 Nov 16;6(1):fcad305. doi: 10.1093/braincomms/fcad305. eCollection 2024.
4
Prediction of misfolded proteins spreading in Alzheimer's disease using machine learning and spreading models.使用机器学习和传播模型预测阿尔茨海默病中错误折叠蛋白的传播。
Cereb Cortex. 2023 Dec 9;33(24):11471-11485. doi: 10.1093/cercor/bhad380.
5
The Use of Tau PET to Stage Alzheimer Disease According to the Braak Staging Framework.使用 Tau PET 根据 Braak 分期框架分期阿尔茨海默病。
J Nucl Med. 2023 Aug;64(8):1171-1178. doi: 10.2967/jnumed.122.265200. Epub 2023 Jun 15.
6
The dynamics of plasma biomarkers across the Alzheimer's continuum.阿尔茨海默病连续体中血浆生物标志物的动态变化。
Alzheimers Res Ther. 2023 Feb 8;15(1):31. doi: 10.1186/s13195-023-01174-0.
7
Predicting conversion of brain β-amyloid positivity in amyloid-negative individuals.预测脑β-淀粉样蛋白阳性的淀粉样阴性个体的转化。
Alzheimers Res Ther. 2022 Sep 12;14(1):129. doi: 10.1186/s13195-022-01067-8.
8
The impact of subthreshold levels of amyloid deposition on conversion to dementia in patients with amyloid-negative amnestic mild cognitive impairment.淀粉样蛋白阴性遗忘型轻度认知障碍患者亚阈值淀粉样蛋白沉积对向痴呆转化的影响。
Alzheimers Res Ther. 2022 Jul 11;14(1):93. doi: 10.1186/s13195-022-01035-2.
9
Regional Aβ-tau interactions promote onset and acceleration of Alzheimer's disease tau spreading.区域 Aβ-tau 相互作用促进阿尔茨海默病 tau 扩散的发病和加速。
Neuron. 2022 Jun 15;110(12):1932-1943.e5. doi: 10.1016/j.neuron.2022.03.034. Epub 2022 Apr 19.
10
Quantification of amyloid PET for future clinical use: a state-of-the-art review.用于未来临床应用的淀粉样 PET 的量化:最新综述。
Eur J Nucl Med Mol Imaging. 2022 Aug;49(10):3508-3528. doi: 10.1007/s00259-022-05784-y. Epub 2022 Apr 7.